CLL
From the Journals
Venetoclax-Obinutuzumab: CLL’s New Power Duo?
Phase 3 study on previously untreated chronic lymphocytic leukemia shows sustained PFS with venetoclax-obinutuzumab.
Feature
Popular Weight Loss Drugs Now for Patients With Cancer?
Research suggests that obesity can reduce the effectiveness of cancer therapies.
Feature
Dr. Rogers’ Neighborhood: Guinea Pigs and Groundbreaking Cancer Care
Ohio State leukemia researcher prioritizes patients’ quality of life -- with a little help from her pets.
From the Journals
Does Medicare Advantage Offer Higher-Value Chemotherapy?
Researchers conducted a cohort study to look at Medicare Advantage enrollment and treatment patterns for patients with cancer receiving...
Feature
AACR Cancer Progress Report: Big Strides and Big Gaps
The report focused on strides made in cancer care, prevention, and early detection and highlighted areas where more research and attention are...
From the Journals
Cancer Risk: Are Pesticides the New Smoking?
A recent study evaluated cancer risks in the US population using a model that accounts for pesticide use and adjusts for various factors.
Conference Coverage
Treatment Options in MCL: What Are the Best Practices?
Experts on mantle cell lymphoma share findings on how best to treat patients at various ages and stages.
Conference Coverage
Debate: Should Patients With CLL Take Breaks From Targeted Therapies?
Experts on chronic lymphocytic leukemia debated whether or not patients would benefit from discontinuing treatment at times.
Conference Coverage
Could Aspirin Avert Bad Outcomes in Leukemia?
A preliminary study finds that aspirin reduces the length and cost of hospital stays in patients with leukemia.
Conference Coverage
To Choose the Best First-line Drug for CML, Consider Efficacy and Cost
For treatment value, imatinib remains the CML gold standard: a generic, second-generation TKI that helps improve treatment-free remission rates....
Feature
Do Clonal Hematopoiesis and Mosaic Chromosomal Alterations Increase Solid Tumor Risk?
Researchers analyzed whole genome sequencing data from 10,866 women in the WHI to explore possible associations between CHIP, mCA, and solid...